Ipilimumab-associated colitis or refractory Clostridium difficile infection? [electronic resource]
Producer: 20160516ISSN:- 1757-790X
- Aged
- Anti-Inflammatory Agents -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Clostridioides difficile -- drug effects
- Colitis -- chemically induced
- Diarrhea -- drug therapy
- Enterocolitis, Pseudomembranous -- complications
- Fluid Therapy -- methods
- Humans
- Ipilimumab
- Male
- Methylprednisolone -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.